Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 28 (FTH1P28) is a processed pseudogene of the ferritin heavy chain 1 (FTH1) gene family. Pseudogenes are genomic sequences similar to known genes but are typically considered nonfunctional due to mutations or lack of regulatory elements necessary for protein expression. FTH1P28 is one of many ferritin pseudogenes widely distributed in the human genome and does not encode a functional protein. Recent evidence suggests some ferritin pseudogenes can be transcribed and may regulate their parental gene expression through competing endogenous RNA (ceRNA) mechanisms, but no evidence exists for FTH1P28 itself being transcribed or having a direct biological function or disease relevance[2][3][4]. It is not considered a therapeutic target, nor is it known to interact with drugs or serve as a disease biomarker. Its only known feature is homology and sequence similarity to the functional FTH1 gene, which encodes a subunit of the cellular iron storage protein ferritin[3][1]. The listing of this pseudogene as a therapeutic target is likely due to a database or annotation error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 28 (FTH1P28).